AbstractID: 8005 Title: Imaging as a Biomarker for Therapy Response: Challenges,
Opportunities and Initiatives
Imaging as a biomarker for drug and radiation therapy response is emerging as an
important area of research. The NIH has formed a Biomarker Consortium with several
agencies of the federal government to leverage NIH and Industry funds to develop
standardized
methods
for
biomarkers
that
includes
imaging.
(http://www.fnih.org/Biomarkers%20Consortium/Biomarkers_home.shtml ). The role of
imaging as a biomarker poses unique problems for image data collection and analysis
across different imaging platforms, as the latter factors increase the uncertainty of
measurement,
(NIST
workshop
agenda
and
report:
http://usms.nist.gov/workshops/bioimaging.htm). The AAPM is well positioned to
address standards for quality assurance for all imaging modalities, system performance,
and development of clinical decision software tools for measurement of therapy response.
For this symposium, speakers will discuss:
The role of imaging as a biomarker,
• Potential funding sources for this work at NIH,
• Leveraging therapy physics experience in the NCI’s Radiation Research Program
that can be applied to measurement of therapy response,
• How imaging societies can become engaged to address this research area and
promote more standardized methods for biomedical imaging.